SynthesisBMC nephrology2014

Economic evaluations of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in type 2 diabetic nephropathy: a systematic review.

Yunyu Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.